 |
|
|
 |
|
Drug Effective Against Heart-Lung Disorder
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 The findings are in the June 21 issue of The Lancet.
"This study broadens the potential for bosentan as a treatment in pulmonary arterial hypertension, and the evidence presented by (the researchers) should soon be translated into clinical practice," Dr. Neeraj Dhaun and Professor David Webb, Queen's Medical Research Institute, University of Edinburgh, U.K., wrote in an accompanying comment.
More information
Text Continues Below

The U.S. National Heart, Lung, and Blood Institute has more about PAH.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 6/19/2008
|
 |

SOURCE: The Lancet, news release, June 20, 2008
|